This trade activity should not be overlooked: Inozyme Pharma Inc (INZY)
With 0.81 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.66 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $4.57 whereas the lowest price it dropped to was $4.39. The 52-week range on INZY shows […]
A better buy-in window may exist right now for Inozyme Pharma Inc (INZY)
With 0.7 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.65 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $4.985 whereas the lowest price it dropped to was $4.6. The 52-week range on INZY shows […]
Check out these key findings about Inozyme Pharma Inc (INZY)
With 1.75 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.6 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $5.68 whereas the lowest price it dropped to was $4.88. The 52-week range on INZY shows […]
The time has not yet come to remove your chips from the table: Inozyme Pharma Inc (INZY)
With 0.71 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.55 million shares. The 52-week range on INZY shows that it touched its highest point at $7.80 and its lowest point at $2.69 during that stretch. It currently has a 1-year price target of $21.00. Beta for […]
Views of Wall Street’s Leading Experts on Inozyme Pharma Inc
With 0.54 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.5 million shares. The 52-week range on INZY shows that it touched its highest point at $7.33 and its lowest point at $2.69 during that stretch. It currently has a 1-year price target of $21.00. Beta for […]
Check out these key findings about Inozyme Pharma Inc (INZY)
With 0.62 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.49 million shares. The 52-week range on INZY shows that it touched its highest point at $7.33 and its lowest point at $2.59 during that stretch. It currently has a 1-year price target of $21.00. Beta for […]
A look into Inozyme Pharma Inc (INZY)’s deeper side
With 0.52 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.49 million shares. The 52-week range on INZY shows that it touched its highest point at $7.33 and its lowest point at $2.51 during that stretch. It currently has a 1-year price target of $21.00. Beta for […]
Check out these key findings about Inozyme Pharma Inc (INZY)
With 0.63 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.46 million shares. The 52-week range on INZY shows that it touched its highest point at $7.33 and its lowest point at $2.51 during that stretch. It currently has a 1-year price target of $21.00. Beta for […]
